Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile,...
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large...
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent...
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform...
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues....
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It...
Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is...
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering...
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris — President & Chief Executive...
Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that...
Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring...
The global healthcare information technology market was valued at $74.2 billion in 2020, and it is expected to grow at...
The technology and healthcare industries have dominated the IPO market in the recent past, but it seems the spotlight is...
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025....
